Ontogo Vascular - Save One More Life, Impact Many

The Critical Problem

Patients are bleeding out and dying from uncontrollable torso hemorrhage. No procedure currently exists to stem bleeding from Non-Compressible Torso Hemorrhages (NCTH) outside the hospital.

Loss of life is not due to the injury but to the loss of blood.

"I see far too many young women & young men die from what are survivable injuries. Patients tragically bleed out from undiagnosed—but treatable—torso hemorrhage, dying from survivable injuries despite modern medicine's capabilities. This is an unacceptable failure we're solving."

- Professor Benjamin Starnes MD, Ontogo Vascular

Our Game-Changing Solution

OV-Control™ – Advancing aortic occlusion with single-step, problem-free deployment and migration resistance, delivering rapid hemorrhage control when every second counts.

Inserted without imaging – Streamlined for emergency use
Deployed in seconds – No complicated steps, just reliable placement
Stays secure – Engineered for stability when it matters most
Supports intermittent perfusion – Balances occlusion with perfusion flexibility
Buys critical time – Enables safer transport for definitive surgical care

OV-Control™ redefines speed and stability in aortic occlusion setting a new standard where others fall short.

Investment Opportunity

Seeking funding to bring OV-Control™ to market and save lives

Defined Market Need

Clear regulatory pathway via FDA 510(k) clearance. Proof of concept to in-market product in just 2 years.

Strong IP Portfolio

Patents protecting key value drivers, including critical 14Fr specification that prevents competitors from using optimal catheter dimensions.

Solid Returns

Direct sales model driving positive Year 4 cashflow. Future growth funded through cashflow and/or debt.

Reimbursement Path

Existing coding within hospitals. Life-saving devices receive premium consideration from CMS and commercial payers.

Market Ready

42% of surgeons now believe aortic occlusion is a valid solution. Clinical opinion is shifting in our favor.

Experienced Team

250+ years of collective experience in MedTech. Proven track record of building successful vascular businesses.

World-Class Leadership Team

Our team brings deep expertise—every member is a seasoned health and medical device professional, collectively delivering 250+ years of proven experience

Prof. Benjamin W. Starnes MD

Co-Founder & Chief Medical Officer

36 Years Experience in Vascular Surgery and Startups

Inventor of OV-Control™, world-renowned vascular surgeon with military and civilian trauma experience. 15-year U.S. Army veteran, former Head of Vascular Surgery at UW/Harborview Medical Center.

Philip Nowell

Co-Founder & President

44 Years Experience in Clinical and Vascular Product Businesses

Extensive commercialization experience in vascular medical devices. Proven track record in building and scaling medical technology businesses globally.

Lynsey Randall

Chief Executive Officer

17 Years Experience in MedTech Vascular Businesses

Proven leadership in scaling MedTech operations with deep expertise in vascular technology commercialization and strategic business development.

Jeremy Barker

Chair & SVP Operations

23 Years Experience in HealthTech Startups and Governance

Strategic business development expertise with extensive experience in HealthTech startup operations and corporate governance.

Tony Pensabene

Director & SVP Sales

50 Years Experience in Medical Device Companies

Veteran medical device sales executive with five decades of experience building and managing exceptional sales teams across global markets.

Mark Morwood

SVP Product

22 Years Experience in MedTech Startups

Product development and engineering leader with extensive experience taking MedTech innovations from concept to commercial success.

Joel Pietropaolo

Chief Growth Officer Sales

18 Years Experience in MedTech Vascular Businesses

Growth-focused sales leader with deep expertise in vascular medical device markets and proven ability to drive revenue expansion.

Chief Operating Officer

To Be Announced

34 Years Experience in MedTech Vascular Businesses

Experienced COO with extensive MedTech vascular business operations expertise ready to join our team.

Save One More Life

The Urgent Need